Option Millionaires

[uranium-pinto-beans]

GME +18.4% (RC Ventures says in 13D filing that it has expressed its views to mgmt)
SAVA +13.5% (director purchases shares)
FLGT +10.2% (to join S&P SmallCap 600)
GNCA +8.2% (FDA has accepted its IND application for GEN-011)
STOR +4% (announces September rent collections of 88% )
BPMC +3.6% (announces top-line results from the Phase 1 EXPLORER and Phase 2 PATHFINDER clinical trials of AYVAKIT in patients with advanced systemic mastocytosis)
UNIT +2.5% (effectiveness of the previously announced settlement with Windstream Holdings Inc. and certain of its subsidiaries, which occurred concurrently with Windstream's emergence from bankruptcy)
TXMD +2.1% (co and Knight Therapeutics announce Health Canada approval of BIJUVA)
HHC +2.1% (CEO retires)
LI +1.6% (announced a three-way strategic cooperation with NVIDIA Corporation)
PSN +0.7% (announces three task orders totaling $69 mln from USAF)
TIF +0.7% (lawsuit against LVMH on fast track, according to Bloomberg)
Analyst comments:

MTDR +3.6% (announces initial boros well results in the Stateline Asset Area)
VRM +7% (upgraded to Buy from Neutral at Goldman)
CVNA +5.9% (upgraded to Buy from Neutral at Goldman)
MTDR +3.6% (upgraded to Buy from Hold at Truist)
BTI +3.2% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
MCFT +2.7% (upgraded to Outperform from Neutral at Robert W. Baird)
AMZN +1.9% (upgraded to Outperform from Mkt Perform at Bernstein)
ONEW +1.5% (upgraded to Outperform from Neutral at Robert W. Baird)
ALL +1.1% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)
POR +0.8% (upgraded to Buy from Neutral at Guggenheim)
TYL +0.8% (upgraded to Outperform from Neutral at Robert W. Baird)